| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 18.401 | 33.780 | 9.125 | 10.108 | 30.564 |
| Total Income - EUR | - | - | - | - | - | 18.401 | 34.426 | 9.125 | 10.108 | 30.585 |
| Total Expenses - EUR | - | - | - | - | - | 427 | 960 | 141 | 1.331 | 6.952 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 17.974 | 33.466 | 8.984 | 8.777 | 23.634 |
| Net Profit/Loss - EUR | - | - | - | - | - | 17.422 | 32.470 | 8.749 | 7.505 | 19.809 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nojuco Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 3 | 3 | 4 | 2.726 |
| Current Assets | - | - | - | - | - | 18.319 | 32.612 | 9.133 | 10.290 | 23.408 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 4.714 | 32.522 | 9.125 | 10.108 | 2.200 |
| Cash | - | - | - | - | - | 13.605 | 91 | 8 | 182 | 21.208 |
| Shareholders Funds | - | - | - | - | - | 17.525 | 32.591 | 8.895 | 7.803 | 19.930 |
| Social Capital | - | - | - | - | - | 103 | 101 | 101 | 101 | 101 |
| Debts | - | - | - | - | - | 794 | 24 | 240 | 2.490 | 6.204 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6202 - 6202" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Nojuco Labs S.r.l.